Bank of America
ARDS

Bank of America’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Bank of America’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$48 – 8496
2022
Q4 		$48 Buy
+40
New +$39 ﹤0.01% 7807
2021
Q2 		– Sell
-28
Closed – – 8243
2021
Q1 		$0 Buy
+28
New +$189 ﹤0.01% 7907
2020
Q3 		– Sell
-39
Closed – – 7288
2020
Q2 		$0 Sell
39
-2,967
-99% -$20.5K ﹤0.01% 7233
2020
Q1 		$17K Buy
3,006
+3,001
+60,020% +$19.1K ﹤0.01% 6230
2019
Q4 		$0 Buy
+5
New +$26 ﹤0.01% 7526
2019
Q3 		– Sell
-114
Closed -$1K – 7604
2019
Q2 		$1K Buy
+114
New +$1.1K ﹤0.01% 7095

Other funds holding ARDS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bank of America's ARDS Position: Q1 2023 in Review

Bank of America sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q1 2023, closing a stake of 40 shares — an estimated $48 sold.

Bank of America first reported a position in ARDS in Q2 2019 and held it in 6 quarters. The position peaked at $17K in Q1 2020. 20 funds tracked by Wall St. Rank hold ARDS as of Q1 2023.

  • Bank of America reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 40 Aridis Pharmaceuticals Inc. Common Stock shares in Q1 2023, an estimated $48.
  • Bank of America first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Bank of America's Aridis Pharmaceuticals Inc. Common Stock position peaked at $17K in Q1 2020.
  • 20 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.